Investigación

Biología molecular y regulación génica del tejido adiposo y sus patologías

Buscador de publicaciones

Publicaciones

  • Ferrer-Curriu G, Guitart-Mampel M, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Villarroya-Gombau F, Fernández-Solà J, Garrabou G and Planavila A.

    The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.

    JOURNAL OF PATHOLOGY . 253(2): 198-208. Nº de citas: 23

    [doi:10.1002/path.5573]

  • Morón S, Uriarte I, Berasain C, Avila MA, Sabater-Masdeu M, Moreno-Navarrete JM, Fernández-Real JM, Giralt M, Villarroya-Gombau F and Gavaldà-Navarro A.

    FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations.

    molecular metabolism . 43: 101113-101113. Nº de citas: 23

    [doi:10.1016/j.molmet.2020.101113]

  • Carneros D, Medina-Gómez G, Giralt M, León-Camacho M, Campbell M, Moreno-Aliaga MJ, Villarroya-Gombau F and Bustos M.

    Cardiotrophin-1 contributes to metabolic adaptations through the regulation of lipid metabolism and to the fasting-induced fatty acid mobilization.

    FASEB JOURNAL . 34(12): 15875-15887. Nº de citas: 2

    [doi:10.1096/fj.202000109R]

  • Campderrós L, Sánchez-Infantes D, Villarroya-Terrade J, Nescolarde L, Bayès-Genis A, Cereijo R, Roca E and Villarroya-Gombau F.

    Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners.

    FRONTIERS IN PHYSIOLOGY . 11: 550102-550102. Nº de citas: 17

    [doi:10.3389/fphys.2020.550102]

  • Frohlich J, Kovacovicova K, Mazza T, Emma MR, Cabibi D, Foti M, Sobolewski C, Oben JA, Peyrou M, Villarroya-Gombau F, Soresi M, Rezzani R, Cervello M, Bonomini F, Alisi A and Vinciguerra M.

    GDF11 induces mild hepatic fibrosis independent of metabolic health.

    Aging-Us . 12(20): 20024-20046. Nº de citas: 13

    [doi:10.18632/aging.104182]

  • Molonia MS, Occhiuto C, Muscarà C, Speciale A, Bashllari R, Villarroya-Gombau F, Saija A, Cimino F and Cristani M.

    Cyanidin-3-O-glucoside restores insulin signaling and reduces inflammation in hypertrophic adipocytes.

    ARCH BIOCHEM BIOPHYS . 691: 108488-108488. Nº de citas: 44

    [doi:10.1016/j.abb.2020.108488]

  • Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya-Gombau F and Vazquez M.

    SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1 alpha-LIPIN 1 pathway and increasing CD36 through Nrf2

    CELL COMMUNICATION AND SIGNALING . 18(1): 147-147. Nº de citas: 27

    [doi:10.1186/s12964-020-00640-8]

  • Domingo P, Villarroya-Gombau F, Giralt M and Domingo JC.

    Potential role of the melanocortin signaling system interference in the excess weight gain associated to some antiretroviral drugs in people living with HIV.

    INTERNATIONAL JOURNAL OF OBESITY . 44(9): 1970-1973. Nº de citas: 23

    [doi:10.1038/s41366-020-0551-5]

  • Dominguez-Gonzalez C, Badosa C, Madruga-Garrido M, Martí I, Paradas C, Ortez-Gonzalez CI, Diaz-Manera J, Berardo A, Alonso-Pérez J, Trifunov S, Cuadras-Palleja D, Kalko-Witruk SG, Blázquez-Bermejo C, Cámara Y, Martí R, Mavillard F, Martin MA, Montoya C, Ruiz-Pesini E, Villarroya-Terrade J, Montero-Sanchez R, Villarroya-Gombau F, Artuch-Iriberri R, Hirano M, Nascimento-Osorio A and Jimenez-Mallebrera C.

    Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy

    SCIENTIFIC REPORTS . 10(1): 10111-10111. Nº de citas: 20

    [doi:10.1038/s41598-020-66940-8]

  • Piquer-Garcia I, Cereijo R, Corral-Pérez J, Pellitero S, Martínez E, Taxerås SD, Tarascó J, Moreno P, Balibrea J, Puig-Domingo M, Serra D, Herrero L, Jiménez-Pavón D, Lerin C, Villarroya-Gombau F and Sánchez-Infantes D.

    Use of Infrared Thermography to Estimate Brown Fat Activation After a Cooling Protocol in Patients with Severe Obesity That Underwent Bariatric Surgery.

    OBESITY SURGERY . 30(6): 2375-2381. Nº de citas: 4

    [doi:10.1007/s11695-020-04502-7]